Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | polo-like kinase 1 | Starlite/ChEMBL | References |
Homo sapiens | polo-like kinase 4 | Starlite/ChEMBL | References |
Homo sapiens | polo-like kinase 3 | Starlite/ChEMBL | References |
Homo sapiens | polo-like kinase 2 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.5047 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.04 | 0.0472 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein | 0.2154 | 0.4067 | 0.3773 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.5047 | 1 | 1 |
Schistosoma mansoni | 6-phosphofructokinase | 0.5047 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.2979 | 0.5759 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.04 | 0.0472 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.4962 | 0.9825 | 0.9817 |
Trichomonas vaginalis | CAMK family protein kinase | 0.04 | 0.0472 | 1 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.2979 | 0.5759 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.04 | 0.0472 | 0.0073 |
Loa Loa (eye worm) | hypothetical protein | 0.4962 | 0.9825 | 0.9817 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.5047 | 1 | 1 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.4962 | 0.9825 | 0.9817 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.2154 | 0.4067 | 0.3773 |
Trichomonas vaginalis | CAMK family protein kinase | 0.04 | 0.0472 | 1 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.2154 | 0.4067 | 0.3773 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.4962 | 0.9825 | 0.9817 |
Trichomonas vaginalis | CAMK family protein kinase | 0.04 | 0.0472 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4962 | 0.9825 | 0.9817 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.04 | 0.0472 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.5047 | 1 | 1 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.2979 | 0.5759 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.2979 | 0.5759 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.04 | 0.0472 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.04 | 0.0472 | 1 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.5047 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.2979 | 0.5759 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.5047 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.2894 | 0.5584 | 0.5366 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.2154 | 0.4067 | 0.3773 |
Onchocerca volvulus | 0.5047 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | = 2 uM | Antiproliferative activity against human HCC1954 cells assessed as growth inhibition after 5 days by SRB assay | ChEMBL. | 23829549 |
IC50 (ADMET) | Inhibition of CYP2C9 (unknown origin) using MFC as substrate after 45 mins by fluorescence assay | ChEMBL. | 23829549 | |
IC50 (ADMET) | Inhibition of CYP2D6 (unknown origin) using AMMC as substrate after 30 mins by fluorescence assay | ChEMBL. | 23829549 | |
IC50 (ADMET) | Inhibition of CYP2C19 (unknown origin) using MFC as substrate after 30 mins by fluorescence assay | ChEMBL. | 23829549 | |
IC50 (ADMET) | Inhibition of CYP3A4 (unknown origin) after 10 mins by fluorescence assay | ChEMBL. | 23829549 | |
IC50 (ADMET) | Inhibition of CYP1A2 (unknown origin) using CEC as substrate after 15 mins by fluorescence assay | ChEMBL. | 23829549 | |
IC50 (binding) | = 0.82 nM | Inhibition of N-terminal GST-tagged human PLK4 (1 to 391 amino acids) expressed in Escherichia coli using TMB as substrate after 30 mins by indirect ELISA assay | ChEMBL. | 23829549 |
IC50 (binding) | > 10 uM | Inhibition of PLK3 (unknown origin) by FRET-based homogeneous assay | ChEMBL. | 23829549 |
IC50 (binding) | > 10 uM | Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay | ChEMBL. | 23829549 |
IC50 (binding) | > 10 uM | Inhibition of PLK1 (unknown origin) by FRET-based homogeneous assay | ChEMBL. | 23829549 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.